STAT

STAT wins long legal fight as Kentucky Supreme Court clears way for release of Purdue OxyContin files

After STAT's yearslong legal fight, secret records about Purdue Pharma’s marketing of OxyContin will finally be made public.

FRANKFORT, Ky. — After a 3 1/2 year legal battle, secret records about Purdue Pharma’s marketing of its potent opioid painkiller OxyContin will finally be made public. The Kentucky Supreme Court denied a request from Purdue to review lower courts’ decisions to release the documents, according to a one-page order received Monday by the lawyers in the case.

The decision is a major victory for STAT, which first filed a motion to unseal the records in March 2016. Purdue has fought to keep the documents out of view, but the Supreme Court’s refusal is final and can’t be appealed.

Now, the public stands to get a glimpse of new information about how in the U.S., many from heroin and the synthetic opioid fentanyl.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

Related Books & Audiobooks